Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors

ConclusionsL3 muscle indexLow is an independent predictor of worse outcomes in NSCLC patients treated with anti-PD-1 inhibitors.

Source: Journal of Cancer Research and Clinical Oncology - February 4, 2020 Category: Cancer & Oncology Source Type: research